Leading Through Setbacks with Cytokinetics’ Robert Blum

Update: 2025-03-11

Description

In this episode of Clinical Trialblazers, host Alberto Grignolo speaks with Robert Blum, president and CEO of Cytokinetics, about his journey from the biology classroom to leading a biopharmaceutical company focused on muscle biology. Robert shares the values that guide his leadership style and how to move forward after failing.

Comments

In Channel

Breaking Barriers in Gene Therapy: Miquel Vila-Perello's Vision for Curing Untreatable Diseases

2025-09-1628:48

Investing in Innovation: Lyla Bibi’s Perspective on Biotech Markets

2025-08-1227:26

The Finnish Formula: Finding Balance and Building Innovation with Dr. Antti Vuolanto

2025-07-1532:28

Leading with Science and Heart: Dr. Ross Breckenridge on Building a Resilient Biotech

2025-06-1035:37

Bedside to Biotech: Dr. Sam Blackman on Building Trust, Storytelling in Science, and Pediatric Cancer Innovation

2025-05-1352:50

From Mentee to CEO, Board Member and Mentor: Insights from Kerrie Brady

2025-04-1537:33

Leading Through Setbacks with Cytokinetics’ Robert Blum

2025-03-1136:30

De-Risking Clinical Trials: Michael Bailey's Patient-First Approach

2025-03-1132:34

Introducing: Clinical Trialblazers!

2025-03-0401:22

Introducing: Clinical Trialblazers

2025-02-2701:22

00:00

1.0x

Leading Through Setbacks with Cytokinetics’ Robert Blum

#box-pro-ellipsis-175972298366153{-webkit-line-clamp:2;}Leading Through Setbacks with Cytokinetics’ Robert Blum

Leading Through Setbacks with Cytokinetics’ Robert Blum

Parexel

Leading Through Setbacks with Cytokinetics’ Robert Blum